Blood group A epitopes do not facilitate entry of SARS‐CoV‐2
Abstract
Information on the impact of ABO blood group (BG) on SARS-CoV-2 infections is conflicting (1-4). To identify risk factors for severe COVID-19 courses we performed a cross-sectional study in volunteers between 18 and 61 years of age registered with DKMS for stem cell donation approved by the Institutional Review Board of the Technische Universität Dresden. All participants provided explicit consent that COVID-19 specific data were linked to genotype data in the donor registry file.
Read the paper
Related studies
- Understanding and treating ejaculatory dysfunction in men with diabetes mellitus
- An Eco-Friendly Solid-State Electrode Modified With ZnO Nanoparticles Decorated With MWCNT as an Electrochemical Sensor for the Determination of Avanafil in Pure Form, Dosage Form and Human Plasma
- Combinations of Freeze-Dried Amorphous Vardenafil Hydrochloride with Saccharides as a Way to Enhance Dissolution Rate and Permeability
- Return to Sport, Reinjury Rate, and Tissue Changes after Muscle Strain Injury: A Narrative Review
- 875: High Prevalence of Significant Comorbid Conditions in Men with Erectile Dysfunction: Momentus Trial Demonstrates Efficacy and Safety of Tadalafil in this Group
- Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.